Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

849 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A reduced intensity conditioning regimen of fludarabine, cyclophosphamide, antithymocyte globulin, plus 2 Gy TBI facilitates successful hematopoietic cell engraftment in an adult with dyskeratosis congenita.
Kharfan-Dabaja MA, Otrock ZK, Bacigalupo A, Mahfouz RA, Geara F, Bazarbachi A. Kharfan-Dabaja MA, et al. Among authors: bacigalupo a. Bone Marrow Transplant. 2012 Sep;47(9):1254-5. doi: 10.1038/bmt.2011.257. Epub 2012 Jan 16. Bone Marrow Transplant. 2012. PMID: 22246089 No abstract available.
The impact of donor-specific antibodies' presence on the outcome post-allogeneic hematopoietic stem cell transplantation: a survey from a single center.
Sica S, Metafuni E, Frioni F, Limongiello MA, Galli E, Sorà F, Bacigalupo A, Poggi E, Feccia MA, Manfreda A, Chiusolo P, Giammarco S. Sica S, et al. Among authors: bacigalupo a. Front Oncol. 2024 Aug 21;14:1387181. doi: 10.3389/fonc.2024.1387181. eCollection 2024. Front Oncol. 2024. PMID: 39234400 Free PMC article.
Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial.
Cavallaro G, Grassi A, Pavoni C, Micò MC, Busca A, Cavattoni IM, Santarone S, Borghero C, Olivieri A, Milone G, Chiusolo P, Musto P, Saccardi R, Patriarca F, Pane F, Saporiti G, Rivela P, Terruzzi E, Cerretti R, Marotta G, Carella AM, Nagler A, Russo D, Corradini P, Bernasconi P, Iori AP, Castagna L, Mordini N, Oldani E, Di Grazia C, Bacigalupo A, Rambaldi A. Cavallaro G, et al. Among authors: bacigalupo a. Blood Cancer J. 2024 Aug 21;14(1):141. doi: 10.1038/s41408-024-01116-5. Blood Cancer J. 2024. PMID: 39168989 Free PMC article. Clinical Trial.
Pure red cell aplasia among ABO mismatched hematopoietic stem cell transplant recipients: a 13-years retrospective study and literature review.
Metafuni E, Busnego Barreto MT, Valentini CG, Giammarco S, Limongiello MA, Sorà F, Bianchi M, Massini G, Piccirillo N, Putzulu R, Frioni F, Bacigalupo A, Teofili L, Chiusolo P, Sica S. Metafuni E, et al. Among authors: bacigalupo a. Front Oncol. 2024 Jul 2;14:1386670. doi: 10.3389/fonc.2024.1386670. eCollection 2024. Front Oncol. 2024. PMID: 39015495 Free PMC article.
849 results